Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Fentanyl dependence, buprenorphine low-dose induction
Ferritin in blood, psychotropic agent effects
Financial incentives, improving adherence
Findings of meta-analyses of the risk of pathological blood clotting
First-choice agents prescribed for tardive dyskinesia (αbetical order; no preference implied)
First-Episode Schizophrenia
first-generation antipsychotics (FGAs)
Fish oils dyslipidaemia treatment mild/moderate depressions in older adults
Fixed-dose regimens, benzodiazepines for alcohol withdrawal management
Flowchart for naloxone administration.
Flow chart for the use of covert medication.
Fluid restriction, hyponatraemia treatment
Flumazenil Acutely disturbed or violent behaviour induction by antidepressants
Flumazenil, guidelines for use of
flunitrazepam, concentration in normal dosing and UK legal limit
Fluoxetine autism spectrum disorder bipolar depression borderline personality disorder bulimia nervosa depression/bipolar disorder in pregnancy suicidality in children and adolescents
Flupentixol bipolar disorder borderline personality disorder long-acting injections doses and frequencies pharmacokinetics
Fluphenazine, smokers
Fluxoxamine for antipsychotic-induced weight gain for tardive dyskinesia smokers
forms T2 and T3, Mental Health Act
forms T4/T5/T6, Mental Health Act
Formulations of drugs impaired absorption following bariatric surgery problems with tablets when tapering
For tardive dyskinesia
FRAMES principles (feedback, responsibility, advice, menu, empathy, self-efficacy), NICE public health guidance on harmful drinking
Frontotemporal dementias
Full blood count, antipsychotic medication monitoring
Gabapentin borderline personality disorder tardive dyskinesia use in patients with hepatic impairment
gabapentinoids (GABA analogues), addiction/physical dependence and withdrawal
Galactorrhea
Galantamine alzheimerâ™s disease mild cognitive impairment